Stocks & Investing
Fri, September 13, 2024
[ Fri, Sep 13th 2024
] - WOPRAI
Wed, August 14, 2024
[ Wed, Aug 14th 2024
] - WOPRAI
Mon, August 12, 2024
[ Mon, Aug 12th 2024
] - WOPRAI
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
Wed, July 31, 2024
[ Wed, Jul 31st 2024
] - WOPRAI
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
Mon, July 8, 2024
[ Mon, Jul 08th 2024
] - WOPRAI
Fri, June 21, 2024
[ Fri, Jun 21st 2024
] - WOPRAI
Thu, May 16, 2024
[ Thu, May 16th 2024
] - WOPRAI
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
Fri, April 26, 2024
[ Fri, Apr 26th 2024
] - WOPRAI
Fri, April 12, 2024
[ Fri, Apr 12th 2024
] - WOPRAI
Thu, March 21, 2024
[ Thu, Mar 21st 2024
] - WOPRAI
Wed, March 20, 2024
[ Wed, Mar 20th 2024
] - WOPRAI
Mon, March 11, 2024
[ Mon, Mar 11th 2024
] - WOPRAI
Thu, February 29, 2024
[ Thu, Feb 29th 2024
] - WOPRAI
Wed, January 24, 2024
[ Wed, Jan 24th 2024
] - WOPRAI
Wed, December 13, 2023
Wed, September 20, 2023
[ Wed, Sep 20th 2023
] - WOPRAI
Wed, August 16, 2023
[ Wed, Aug 16th 2023
] - WOPRAI
Fri, August 11, 2023
[ Fri, Aug 11th 2023
] - WOPRAI
Mon, August 7, 2023
[ Mon, Aug 07th 2023
] - WOPRAI
Thu, July 6, 2023
[ Thu, Jul 06th 2023
] - WOPRAI
Mon, July 3, 2023
[ Mon, Jul 03rd 2023
] - WOPRAI
Fri, June 16, 2023
[ Fri, Jun 16th 2023
] - WOPRAI
Thu, April 13, 2023
[ Thu, Apr 13th 2023
] - WOPRAI
Tue, February 28, 2023
[ Tue, Feb 28th 2023
] - WOPRAI
Fri, February 24, 2023
[ Fri, Feb 24th 2023
] - WOPRAI
Wed, February 8, 2023
[ Wed, Feb 08th 2023
] - WOPRAI
Wed, February 1, 2023
[ Wed, Feb 01st 2023
] - WOPRAI
Whitney Ijem Maintained (BMRN) at Hold and Held Target at $93 on, Sep 13th, 2024
Whitney Ijem of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $93 on, Sep 13th, 2024.
Whitney has made no other calls on BMRN in the last 4 months.
There are 13 other peers that have a rating on BMRN. Out of the 13 peers that are also analyzing BMRN, 3 agree with Whitney's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Thursday, September 5th, 2024
- George Farmer of "Scotiabank" Maintained at Hold with Increased Target to $95 on, Thursday, September 5th, 2024
- Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024
These are the ratings of the 10 analyists that currently disagree with Whitney
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $118 on, Thursday, September 5th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $115 on, Wednesday, August 21st, 2024
- William Pickering of "Bernstein" Upgraded from Hold to Buy and Increased Target to $110 on, Tuesday, August 20th, 2024
- Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, June 27th, 2024
